Form D · Pharmaceuticals
PAIN THERAPEUTICS INC
Austin, TX · CIK 0001069530
Offering snapshot reported Aug 30, 2018 · SEC filing
- Reported sold
- $1.11M Offering amount: $1.11M
- Investors reported
- 13 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 15, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 30, 2018 | Initial | $1,107,597 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $77.5K
- Finders' fees
- $0
- Form D file number
- 021-320389
The issuer will pay a cash fee to H.C. Wainwright equal to 7.00% of the aggregate gross proceeds raised.
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| H.C. Wainwright & Co., LLC | 375 |
Source: Form D, filed Aug 30, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Remi Barbier | Director, Executive |
| Nadav Friedmann | Director, Executive |
| Robert Gussin | Director |
| Michael O'donnell | Director |
| Saira Ramasastry | Director |
| Sanford Robertson | Director |
| Patrick Scannon | Director |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
7801 N Capital Of Texas Highway Suite 260
Austin, TX, 78731
Austin, TX, 78731